[1] |
蔡后荣,李惠萍.实用间质性肺疾病[M].北京:人民卫生出版社,2010:12.
|
[2] |
Murata K,Fujimoto K,Kitaguchi Y,et al.Hydrogen peroxide content and pH of expired breath condensate from patients with asthma and COPD[J].COPD,2014,11(1):81-87.
|
[3] |
巫翠华,黄立霞,李志莹,等.持续气道正压通气对阻塞性睡眠呼吸暂停低通气综合征呼气冷凝液内皮素-1水平的影响[J].中国医药导报,2015,12(1):30-34.
|
[4] |
Piotrowski WJ,Antczak A,Marczak J,et al.Eicosanoids in exhaled breath condensate and BAL fluid of patients with sarcoidosis[J].Chest,2007,132(2):589-596.
|
[5] |
Tufvesson E,Bozovic G,Hesselstrand R,et al.Increased cysteinyl-leukotrienes and 8-isoprostane in exhaled breath condensate from systemic sclerosis patients[J].Rheumatology(Oxford),2010,49(12):2322-2326.
|
[7] |
中国医师协会呼吸医师分会.无创气道炎症评估支气管哮喘的临床应用中国专家共识[J].中华结核和呼吸杂志,2015,38(5):329-341.
|
[10] |
结节病诊断及治疗方案(第三次修订稿草案)[J].中华结核和呼吸杂志,1994,17(1):9-10.
|
[13] |
胡玉洁,黄文杰.氧化应激促进肺间质纤维化的机制[J].国际呼吸杂志,2012,32(8):605-607.
|
[6] |
Psathakis K,Papatheodorou G,Plataki M,et al.8-iso-PG,a marker of oxidative stress,is increased in the expired breath condensate of patients with pulmonary sarcoidosis[J].Chest,2004,125(3):1005-1011.
|
[8] |
American Thoracic Society,European Respiratory Society.American thoracic Society European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias[J].Am J Respir Crit Care Med,2002,165(2):277-304.
|
[9] |
Travis WD,Costabel U,Hansell DM,et al.An Official American Thoracic Society /European Respiratory Society Statement:Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias[J].Am J Respir Crit Care Med,2013,188(6):733-748.
|
[11] |
Bargagli E,Olivieri C,Bennett D,et al.Oxidative stress in the pathogenesis of diffuse lung diseases:a review [J].Respir Med,2009,103(9):1245-1256.
|
[12] |
Shimizu Y,Dobashi K,Sano T,et al.ROCK activation in lung of idiopathic pulmonary fibrosis with oxidative stress[J].Int J Immunopathol Pharmacol,2014,27(1):37-44.
|
[14] |
Montuschi P,Kharitonov SA,Ciabattoni G,et al.Exhaled 8-iso-PG as a new non-invasive biomarker of oxidative stress in cystic fibrosis[J].Thorax,2000,55(3):205-209.
|
[15] |
Malli F,Bardaka F,Tsilioni I,et al.8-iso-PG levels in serum and bronchoalveolar lavage in idiopathic pulmonary fibrosis and sarcoidosis[J].Food Chem Toxicol,2013,(61):160-163.
|
[16] |
Piotrowski WJ,Kurmanowska Z,Antczak A,et al.Exhaled 8-iso-PG as a prognostic marker in sarcoidosis.A short term follow-up[J].BMC Pulm Med,2010,(10):23.
|
[17] |
Lehtonen H,Oksa P,Lehtimaki L,et al.Increased alveolar nitric oxide concentration and high levels of leukotriene B(4)and 8-iso-PG in exhaled breath condensate in patients with asbestosis[J].Thorax,2007,62(7):602-607.
|
[18] |
侯显明,于润江.间质性肺病学[M].北京:人民卫生出版社,2003:3-9.
|
[19] |
李小莉,黄平,杜秀芳.慢性阻塞性肺疾病治疗期间呼出气冷凝液中8-异前列腺素、IL-6、IL-10的变化及与气道炎症的相关性研究[J].中国呼吸与危重监护杂志,2014,13(5):445-448.
|
[20] |
Keskin O,Balaban S,Keskin M,et al.Relationship between exhaled leukotriene and 8-isoprostane levels and asthma severity,asthma control level,and asthma control test score[J].Allergol Immunopathol(Madr),2014,42(3):191-197.
|
[21] |
Pelclova D,Fenclova Z,Kacer P,et al.8-iso-PG and leukotrienes in exhaled breath condensate in Czech subjects with silicosis[J].Ind Health,2007,45(6):766-774.
|
[22] |
Kinnula VL,Fattman CL,Tan RJ,et al.Oxidative stress in pulmonary fibrosis:a possible role for redox modulatory therapy[J].Am J Respir Crit Care Med,2005,172(4):417-422.
|